Two Sigma Advisers’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Two Sigma Advisers’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-75,181	Closed	-$3.61M	–	2669
2020 Q1	$3.61M	Sell	75,181 -9,619	-11%	-$447K	0.01%	842
2019 Q4	$3.98M	Sell	84,800 -16,900	-17%	-$747K	0.01%	939
2019 Q3	$2.4M	Buy	101,700 +9,000	+10%	+$267K	0.01%	1035
2019 Q2	$2.79M	Buy	92,700 +20,200	+28%	+$463K	0.01%	1062
2019 Q1	$1.62M	Buy	72,500 +26,800	+59%	+$576K	﹤0.01%	1311
2018 Q4	$832K	Buy	45,700 +4,000	+10%	+$62.8K	﹤0.01%	1570
2018 Q3	$754K	Sell	41,700 -18,900	-31%	-$224K	﹤0.01%	1621
2018 Q2	$603K	Buy	60,600 +43,200	+248%	+$298K	﹤0.01%	1844
2018 Q1	$92K	Buy	+17,400	New	+$124K	﹤0.01%	2230

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Two Sigma Advisers's RARX Position: Q2 2020 in Review

Two Sigma Advisers sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 75,181 shares — an estimated $3.61M sold.

Two Sigma Advisers first reported a position in RARX in Q1 2018 and held it in 9 quarters. The position peaked at $3.98M in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Two Sigma Advisers reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Two Sigma Advisers sold 75,181 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $3.61M.
Two Sigma Advisers first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
Two Sigma Advisers's Ra Pharmaceuticals, Inc. Common Stock position peaked at $3.98M in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Two Sigma Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.